SANGUEDOLCE, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 3.316
NA - Nord America 2.527
AS - Asia 963
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 12
OC - Oceania 9
AF - Africa 5
Totale 6.844
Nazione #
US - Stati Uniti d'America 2.520
IE - Irlanda 1.370
CN - Cina 694
SE - Svezia 638
UA - Ucraina 520
IT - Italia 327
FR - Francia 129
SG - Singapore 107
FI - Finlandia 93
IN - India 90
DE - Germania 70
GB - Regno Unito 62
TR - Turchia 59
CZ - Repubblica Ceca 37
ES - Italia 13
GR - Grecia 11
EU - Europa 10
AU - Australia 9
BE - Belgio 9
RU - Federazione Russa 9
CL - Cile 7
NL - Olanda 6
AT - Austria 5
CA - Canada 5
IR - Iran 5
PL - Polonia 5
BR - Brasile 4
JP - Giappone 3
RO - Romania 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
MG - Madagascar 2
MK - Macedonia 2
CH - Svizzera 1
DK - Danimarca 1
EG - Egitto 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.844
Città #
Dublin 1.370
Chandler 486
Nyköping 480
Jacksonville 357
Dearborn 222
New York 183
Nanjing 164
Princeton 141
Ashburn 95
Wilmington 90
Nanchang 78
Singapore 70
Beijing 68
Helsinki 51
San Mateo 51
Shenyang 51
Ann Arbor 39
Boardman 37
Los Angeles 36
Rome 29
Foggia 27
Hebei 27
Tianjin 27
Brno 24
Jiaxing 23
Kunming 23
Bari 22
Munich 22
Pune 22
Jinan 21
Milan 21
Des Moines 18
Shanghai 18
Guangzhou 17
Hangzhou 17
Changsha 16
Olomouc 13
Seattle 12
Reading 11
Taizhou 10
Washington 10
Zhengzhou 10
Brussels 9
Ningbo 9
Norwalk 9
Borås 8
London 8
Redwood City 8
Woodbridge 8
Wuhan 8
Changchun 7
Marousi 7
Orange 7
Fuzhou 6
Chengdu 5
Chicago 5
Clearwater 5
Genoa 5
Hobart 5
Madrid 5
Pescara 5
Voghera 5
Hanover 4
Lavagna 4
Naples 4
Paris 4
Villasanta 4
Xi'an 4
Andria 3
Bitonto 3
Casalgrande 3
Dalian 3
Florence 3
Houston 3
Isola del Liri 3
Jinhua 3
Leawood 3
Novokuznetsk 3
Rui'an 3
San Jose 3
San Severo 3
Santa Cruz de Tenerife 3
Shenzhen 3
Slough 3
Strasbourg 3
Tehran 3
Treviolo 3
Valencia 3
Xuzhou 3
Ariccia 2
Asiago 2
Athens 2
Austin 2
Banja Luka 2
Bisceglie 2
Bitetto 2
Bologna 2
Borgo San Lorenzo 2
Brescia 2
Budapest 2
Totale 4.752
Nome #
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 150
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 132
A recurrent epidermoid cyst of the spleen: report of a case and literature review 117
Un caso di sarcoma di Kaposi viscerale in un paziente con morbo di crohn duodenale e immunodeficienza congenita. 107
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 101
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 99
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 97
Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy 91
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 91
Cyclooxygenase isozymes 1 and 2 in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations 90
Epigenetic inactivation of the WNT-pathway genes in oral squamous cell carcinoma. Preliminary report 89
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 88
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 86
Surgicel (R) granuloma mimicking ovarian cancer: A case report 86
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 84
Voluminous Omental Inflammatory Myofibroblastic Tumor in an Elderly Man: A Case Report and Literature Review 83
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 83
Epigenetic silencing of wnt-inhibitors: activation of a constitutive wnt signalling in oral cancer 82
Hemoperitoneum due to breaking uterine adenosarcoma located in the omentum. Report of a case 80
One stage surgery for synchronous liver metastasis from a neuroendocrine tumor of the colon. A case report 80
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 79
Asymptomatic solitary bladder plasmocytoma: A case report and literature review 79
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer 79
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 79
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 77
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 75
A lycopene and olives vegetation water compound improves lower urinary tract symptoms in men with histologically-proven benign prostatic hyperplasia and inflammation 75
A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study. 74
Pospho-protein-runx-2 expression is a prognostic marker of metastatic prostate carcinoma. 74
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 74
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 73
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 72
Role of age in prostate and bladder cancer. A critical overview 72
ARE WE DOING OUR BEST TO PREVENT THE (UNEXPECTED) DISAPPOINTING SIDE EFFECTS OF AN OTHERWISE SUCCESSFUL CANCER TREATMENT? 71
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 70
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 70
Magnetic resonance imaging of penile paraffinoma: Case report 69
Can inspection of the mouth help clinicians diagnose Crohn's disease? A review 69
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 68
Daily tadalafil for the chronic phase of stuttering priapism: A case report 68
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review 66
Detection of novel Human papilloma virus type 82 in laryngeal cancer: case report. 66
An unusual delayed complication of paraffin self-injection for penile girth augmentation. 64
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 64
Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm 64
Molecular markers in bladder cancer: Novel research frontiers 64
p-NFkB expression in thyroid cancer. 63
Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. 61
Asymptomatic bladder metastasis from breast cancer. 61
Ectopic manifestation of a cholesterol granuloma in the nasopalatine duct 61
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 60
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy 60
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 58
Simultaneous radical nephroureterectomy and transurethral distal ureter balloon occlusion and detachment 58
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 57
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 57
Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: A case report 57
Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets 57
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 56
Bladder metastasis from lung adenocarcinoma: a difficult differential diagnosis with primary bladder adenocarcinoma. 55
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 55
Multiple Skeletal Muscle Metastases from Colon Carcinoma Preceded by Paraneoplastic Dermatomyositis 52
Micropapillary bladder cancer, a variant histology of the elderly 52
Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use? 51
Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions 51
The complex relationship between upper urinary tract and bladder cancer: Clinical and predictive issues 51
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 51
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 50
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 50
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 50
Pilonidal cyst of the penis mimicking carcinoma. 49
Surgicel® granuloma mimicking ovarian cancer: A case report 49
Elderly patients and prostate biopsy. How old is too old? 49
Increased expression of the autocrine motility factor is associated with poor prognosis in patients with clear cell-renal cell carcinoma 48
The broad landscape of follicular lymphoma: Part I 48
Epidermoid cyst of the coronal sulcus mimicking penile cancer: a case report. 47
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 47
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 47
Prostate cancer biomarkers: a practical review based on different clinical scenarios 47
Modulation of complement activation by pentraxin-3 in prostate cancer 46
Osseous metaplasia within a urothelial bladder cancer nodal metastasis: a case report. 43
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 43
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 43
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 42
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 41
SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications 41
Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review 40
Urinary tract large cell neuroendocrine carcinoma: Diagnostic, prognostic and therapeutic issues 40
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 40
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 38
Molecular markers predicting disease outcome in bladder cancer. Should we shift from the classical cell-cycle regulators to her2 oncogene? 35
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  35
Prognostic and therapeutic role of HER2 expression in micropapillary carcinoma of the bladder 34
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere? 33
Benign Lymphoepithelial Cyst of the Parotid Gland: Mind the Underlying Cause 33
Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study 31
T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic Marker 30
PD-L1 as a prognostic and predictive biomarker in neuroendocrine tumors of the lung: state of the art and future perspectives 27
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 26
T-cell prolymphocytic leukemia: Insidious onset followed by aggressive course with cutaneous involvement 26
Totale 6.303
Categoria #
all - tutte 50.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020776 0 0 107 7 138 130 163 12 90 22 94 13
2020/2021611 90 5 74 12 81 12 89 33 97 98 11 9
2021/2022796 58 12 38 12 45 8 91 60 98 149 27 198
2022/20232.989 261 181 146 107 144 229 10 222 1.522 44 55 68
2023/2024811 83 37 36 20 38 273 72 38 10 23 41 140
2024/2025202 151 51 0 0 0 0 0 0 0 0 0 0
Totale 7.354